We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Injectable Gels Could Repair Disc Degeneration

By HospiMedica International staff writers
Posted on 07 Jun 2011
Nanoscopic polymer particles with unique swelling and mechanical properties that can transform into a gel could help restore the mechanical properties of damaged intervertebral discs (IVDs).

Researchers at the University of Manchester (United Kingdom) have succeeded in developing doubly crosslinked (DX) microgels, a new type of hydrogel that are constructed from covalently linked, singly crosslinked (SX) microgels. More...
Linking the microgel particles together--using covalent linking of physically gelled dispersions of interpenetrating, vinyl-functionalized microgels--formed durable, elastic gels capable of sustaining large permanent changes in shape without breaking. These improved injectable gels have much better mechanical properties than the first generation SX microgels, and the researchers say they now display the necessary long-term durability required for an implanted device.

The relationships between DX microgel composition and mechanical properties were investigated using dynamic rheology and swelling experiments; yield strains could be varied between 5-65%. The ability to tune the mechanical properties of the DX microgels and control of intra- and inter-particle crosslinking is achieved using preparation conditions, including Ph regulation, resulting in microgels that have the potential to be used as injectable gels for soft and load-bearing tissue repair. The study describing the development and properties of the new microgels was published in the May 15, 2011, issue of the journal Soft Matter.

"Degeneration of the intervertebral disc results in chronic back pain which costs the country billions of pounds per annum and causes untold misery for sufferers and their families," said study coauthor Prof. Tony Freemont, PhD, head of research in the school of biomedicine. "We have been working for 25 years to identify methods for treating degeneration of the intervertebral disc."

Related Links:

University of Manchester




New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Desk Aneroid Sphyg
Diagnostix 750D+
New
Hypodermic Syringe
SurTract™ Safety Syringe
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Health IT

view channel
Photo courtesy of Adobe Stock

Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings

Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.